Motivations and Barriers to Participating in Ophthalmology Research Projects
Sponsor
Manchester University NHS Foundation Trust (Other)
Overall Status
Recruiting
CT.gov ID
NCT04404803
Collaborator
(none)
1,000
1
59.3
16.9
Study Details
Study Description
Brief Summary
The primary objective of this project is to understand the reasons why patients agree / disagree to take part in ophthalmology research. This will be done by asking participants to complete a Research Questionnaire.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
1000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Motivations and Barriers to Participating in Ophthalmology Research Projects
Actual Study Start Date
:
Jan 21, 2019
Anticipated Primary Completion Date
:
Jan 1, 2024
Anticipated Study Completion Date
:
Jan 1, 2024
Outcome Measures
Primary Outcome Measures
- Assessment of motivations to participating in ophthalmology research. [5 years]
Questionnaire
- Assessment of barriers in participating in ophthalmology research [5 years]
Questionnaire
Eligibility Criteria
Criteria
Ages Eligible for Study:
16 Years
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
-
Over 16 years old
-
Willing to participate by completing the questionnaire
-
Must be able to speak and read English
Exclusion Criteria:
-
Under 16 years of age
-
Not willing to complete the questionnaire
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Monika Cien | Manchester | United Kingdom | M13 9WL |
Sponsors and Collaborators
- Manchester University NHS Foundation Trust
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Manchester University NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT04404803
Other Study ID Numbers:
- B00366
First Posted:
May 28, 2020
Last Update Posted:
Jun 1, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: